Predictive Efficacy of Modified Caprini Score and D-Dimer for the Evaluation and Management of Lower Extremity Venous Thrombosis Among Cardiothoracic Surgery Patients in Baghdad

What this Trial Is About

This research aims to evaluate how well the Modified Caprini Risk Assessment Score combined with D-Dimer levels can predict and help manage lower extremity venous thrombosis (LEVT) in patients undergoing cardiothoracic surgery in Baghdad. The study focuses on whether using both tools together improves accuracy compared to using each alone and how they can guide prevention and treatment decisions. LEVT, which includes deep vein thrombosis and pulmonary embolism, poses significant risks after surgery, especially within the first six weeks post-operation. Participants will have their LEVT risk assessed using the Modified Caprini Score before surgery and have their D-Dimer blood levels measured after surgery. Depending on the doctor's decision, they may receive graduated compression stockings or low-molecular-weight heparin after the procedure. The study observes patients during their hospital stay and follows them up on days 7, 15, and 30 post-discharge to monitor for any venous thromboembolism events or complications. During the study, patients will undergo risk assessments, blood tests, and clinical monitoring to track any episodes of venous thromboembolism, including pulmonary embolism and recurrent deep vein thrombosis. Data collection includes preoperative Caprini scores and postoperative D-Dimer levels. Patients are followed closely during their hospital stay, averaging 7 days, and continue to be monitored for 30 days after discharge to assess outcomes and guide clinical decisions for thrombosis management.

Predictive Value of Modified Caprini Score and D-Dimer in Managing Lower Limb Venous Thrombosis in Cardiothoracic Patients